M. Adorni

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M.p. Adorni, M. P. Adorni, Maria-pia Adorni, Maria Pia Adorni, M P Adorni
Publication record
136 papers · 2,907 citations · H-index 28

PAPERS

Divergent regulation of cellular cholesterol metabolism by seaweed-derived fucosterol and saringosterol
20250 citationsauthor #16
Pro-Inflammatory and Lipid Metabolism Dysregulating Effects of ANGPTL3 in THP-1 Macrophages
20250 citationsauthor #5
Mechanisms, Mediators, and Pharmacological Approaches Targeting Brain Cholesterol Transport in Alzheimer's Disease.
20250 citationsauthor #6
Effect of natural and synthetic PCSK9 inhibitors on Alzheimer’s disease-related parameters in human cerebral cell models
20241 citationsauthor #3
POS0667 VARIATIONS IN MACROPHAGE CHOLESTEROL LOADING OVER TIME ARE LINKED TO DYNAMIC CHANGES IN CORONARY ATHEROSCLEROSIS BURDEN IN RHEUMATOID ARTHRITIS
20240 citationsauthor #6
Gene Silencing of Angiopoietin-like 3 (ANGPTL3) Induced De Novo Lipogenesis and Lipid Accumulation in Huh7 Cell Line
20243 citationsauthor #4
Bioactive Alkaloids from Nepalese Corydalis chaerophylla D.C. Acting on the Regulation of PCSK9 and LDL‐R In Vitro
20241 citationsauthor #9
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum
20246 citationsauthor #3
Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis
20244 citationsauthor #6
HDL cholesterol efflux capacity and cholesterol loading capacity in long-term fasting: Evidence from a prospective, single-arm interventional study in healthy individuals.
20243 citationsauthor #3
Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9
20249 citationsauthor #4
Identification of new side chain oxidized sterols as novel liver X receptor agonists with therapeutic potential in the treatment of cardiovascular and neurodegenerative diseases
20240 citationsauthor #16
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity
20230 citationsauthor #5
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases.
20235 citationsauthor #3
Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis
20237 citationsauthor #6
POS0343 STATINS INFLUENCE THE RELATIONSHIP BETWEEN ATP-BINDING CASSETTE TRANSPORTER A1 (ABCA1)-MEDIATED CHOLESTEROL EFFLUX AND CORONARY ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS
20231 citationsauthor #6
Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism
202310 citationsauthor #1
Long-term fasting effect on HDL cholesterol efflux and serum cholesterol loading capacity: Preliminary results from a single-arm interventional trial
20230 citationsauthor #2
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefence
20234 citationsauthor #3
Cyclic fasting bolsters cholesterol biosynthesis inhibitors’ anticancer activity
202310 citationsauthor #5
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC
202312 citationsauthor #1
Hydroxypropyl-β-Cyclodextrin Depletes Membrane Cholesterol and Inhibits SARS-CoV-2 Entry into HEK293T-ACEhi Cells
202310 citationsauthor #5
Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases
202312 citationsauthor #16
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis.
20236 citationsauthor #6
POS0915 ATP-BINDING CASSETTE G1 MEMBRANE TRANSPORTER-MEDIATED CHOLESTEROL EFFLUX CAPACITY INFLUENCES CORONARY ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS
20230 citationsauthor #6
Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis
20235 citationsauthor #6
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line
20230 citationsauthor #9
Intracellular proprotein convertase subtilisin/kexin type 9 and inflammation: Unveiling the role of extracellular vesicles in atheroma formation
20230 citationsauthor #8
Deciphering the molecular mechanisms underlying the increase in PCSK9 plasma levels in response to anti-PCSK9 mabs: In vitro study in human hepatoma-derived Huh7 cells
20220 citationsauthor #5
Inhibition of PCSK9 affects serum lipoprotein functions in patients with familial hypercholesterolemia
20220 citationsauthor #2
Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates cholesterol homeostasis and neuroinflammation in cell models of astrocytes and neurons
20220 citationsauthor #3
Cerebrospinal fluid and serum HDL cholesterol efflux capacity is impaired in neurodegenerative disorders
20220 citationsauthor #2
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation
202215 citationsauthor #13
Cholesterol efflux capacity of high-density lipoprotein particles is impaired in age-related macular degeneration patients with high plasma HDL-C levels
20220 citationsauthor #7
Nutrition Intervention and Cardiovascular Disease
20225 citationsauthor #1
Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis
202212 citationsauthor #6
Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders.
202244 citationsauthor #3
HDL metabolism and functions impacting on cell cholesterol homeostasis are specifically altered in patients with abdominal aortic aneurysm
20226 citationsauthor #1
Serum and cerebrospinal fluid concentrations of PCSK9 and hydroxysterols in patients with cognitive impairment
20221 citationsauthor #4
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma
20225 citationsauthor #1
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells
202221 citationsauthor #8
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
202226 citationsauthor #2
Achilles tendon xanthoma thickness associates to serum lipoprotein functions alterations
20220 citationsauthor #1
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
202183 citationsauthor #1
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity.
202119 citationsauthor #2
Hormone therapy impacts on HDL-CEC but not on HDL subclasses and serum loading capacity: A cohort of transgender individuals.
20210 citationsauthor #2
PCSK9 modulates brain cholesterol metabolism and neuroinflammation in human cell models of astrocytes and neurons
20211 citationsauthor #3
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review
202141 citationsauthor #2
PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin
202111 citationsauthor #3
Drug-drug interactions in polypharmacy patients: The impact of renal impairment
202132 citationsauthor #3
Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure
202136 citationsauthor #3
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study
202114 citationsauthor #5
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study
202025 citationsauthor #4
HDL Proteome and Alzheimer’s Disease: Evidence of a Link
202051 citationsauthor #2
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL.
20204 citationsauthor #4
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia.
202065 citationsauthor #3
Lipoprotein metabolism and function are altered in patients with abdominal aortic aneurysm
20200 citationsauthor #2
Naturally Occurring PCSK9 Inhibitors
202077 citationsauthor #1
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line
202013 citationsauthor #5
Infusions of Large Synthetic HDL Containing Trimeric apoA-I Stabilize Atherosclerotic Plaques in Hypercholesterolemic Rabbits.
201919 citationsauthor #2
Male patients with hypogonadism have an impaired lipoprotein function
20190 citationsauthor #2
Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
201961 citationsauthor #1
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease[S]
201953 citationsauthor #2
High-Density Lipoprotein Function Is Reduced in Patients Affected by Genetic or Idiopathic Hypogonadism.
201924 citationsauthor #1
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients
201924 citationsauthor #2
The Capacity Of Cerebrospinal Fluid To Promote Cholesterol Efflux Through Abca1 And Abcg1 Is Specifically Impaired In Alzheimer’S Disease Patients
20190 citationsauthor #3
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians[S]
201821 citationsauthor #5
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.
201817 citationsauthor #3
PCSK9 induces a pro-inflammatory response in macrophages
2018183 citationsauthor #9
Cholesterol efflux capacity of healthy octogenarians does not associate with coronary calcium, plaque vulnerability and telomere length
20180 citationsauthor #5
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.
2017115 citationsauthor #1
Role of Sphingosine 1-phosphate (S1P) and its receptor S1P3 in the reverse cholesterol transport
20170 citationsauthor #5
Improvement of cell cholesterol trafficking-related lipoprotein functions in rheumatoid arthritis patients treated with tocilizumab
20170 citationsauthor #3
effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCsK9
20170 citationsauthor #1
Effect of a novel nutraceutical combination on serum lipoprotein functional profile and circulating PCSK9
201723 citationsauthor #1
PCSK9 induces a pro-inflammatory response in macrophages.
201722 citationsauthor #9
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women.
20170 citationsauthor #5
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure
20172 citationsauthor #2
Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction[S]
201744 citationsauthor #4
and function Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction patient-oriented and epidemiological research
20170 citationsauthor #4
Abstract 12124: Vitamin D Replacement Ameliorates Serum Lipoprotein Functions, Adipokine Profile and Subclinical Atherosclerosis in Pre-menopausal Women
20170 citationsauthor #3
Evaluation of hdl cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics
20160 citationsauthor #3
Improvement of lipoprotein functions related to cell cholesterol trafficking in rheumatoid arthritis patients treated with tocilizumab
20160 citationsauthor #3
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease
201662 citationsauthor #5
Lomitapide affects HDL composition and function.
201614 citationsauthor #6
Vitamin D status and HDL functionality in healthy pre-menopausal women
20160 citationsauthor #4
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla).
20156 citationsauthor #5
Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism
2015121 citationsauthor #3
A single infusion of trimeric apoA-I in hypercholesterolemic rabbits stabilizes atherosclerotic plaques and increases plasma cholesterol efflux capacity
20150 citationsauthor #3
Impaired hdl cholesterol efflux capacity during development of pacing-induced heart failure in minipig
20150 citationsauthor #2
New mechanisms for steroid pro-atherogenic action: Up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracellular cholesterol stores
20151 citationsauthor #3
Lomitapide treatment highly affects lipoprotein profile and HDL functionality in patients with familial hypercholesterolemia
20150 citationsauthor #3
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function.
201524 citationsauthor #2
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome.
201515 citationsauthor #3
The natural compound berberine positively affects macrophage functions involved in atherogenesis.
201538 citationsauthor #2
Effect of Tetranectin-ApoA-I infusion on atherosclerosis and HDL-mediated cholesterol efflux capacity in hypercholesterolemic rabbits
20150 citationsauthor #2
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease.
201521 citationsauthor #4
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity
20150 citationsauthor #3
Cholesterol trafficking-related serum lipoprotein functions in childrens with cholesteryl ester storage disease
20150 citationsauthor #1
Hydrocortisone directly promotes cholesterol accumulation in macrophages
201414 citationsauthor #3

TIMELINE

2004 0 citations

2005 24 citations

2006 0 citations

2007 318 citations

2008 1 citations

2009 394 citations

2010 0 citations

2011 23 citations

2012 208 citations

2013 308 citations

2014 14 citations

2015 226 citations

2016 76 citations

2017 206 citations

2018 221 citations

2019 181 citations

2020 235 citations

2021 237 citations

2022 135 citations

2023 82 citations

2024 27 citations

2025 0 citations

M. Adorni

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT